Göran Landberg (Former)
71 – 80 of 119
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance
- Contribution to journal › Article
-
Mark
Increased expression of cyclin A1 protein is associated with all-trans retinoic acid-induced apoptosis.
- Contribution to journal › Article
-
Mark
Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
- Contribution to journal › Article
-
Mark
High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients.
- Contribution to journal › Article
-
Mark
MTA1, a transcriptional activator of breast cancer amplified sequence 3
- Contribution to journal › Article
-
Mark
Cyclin e overexpression reduces infiltrative growth in breast cancer - Yet another link between proliferation control and tumor invasion
- Contribution to journal › Article
-
Mark
Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer
- Contribution to journal › Article
-
Mark
Cyclin A1 expression and associations with disease characteristics in childhood acute lymphoblastic leukemia.
(2006) In Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis 30(3). p.254-261
- Contribution to journal › Article
-
Mark
Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.
- Contribution to journal › Article
- 2005
-
Mark
ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells.
- Contribution to journal › Article
